We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Core Laboratories Inc. (CLB) - free report >>
Tenaris S.A. (TS) - free report >>
CrossAmerica Partners LP (CAPL) - free report >>
Image: Bigstock
New Strong Sell Stocks for January 16th
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
CrossAmerica Partners LP (CAPL - Free Report) engages in the wholesale distribution of motor fuels, and ownership and leasing of real estate used in the retail distribution of motor fuels. The Zacks Consensus Estimate for its current year earnings has been revised 10.5% downward over the last 60 days.
Tenaris S.A. (TS - Free Report) is a company that produces and sells seamless and welded steel tubular products. The Zacks Consensus Estimate for its current year earnings has been revised 0.8% downward over the last 60 days.
Core Laboratories N.V. (CLB - Free Report) is a company that provides reservoir description and production enhancement services and products to the oil and gas industry. The Zacks Consensus Estimate for its current year earnings has been revised 2.2% downward over the last 60 days.
Cidara Therapeutics, Inc. (CDTX - Free Report) is a biotechnology company that focuses on the discovery, development, and commercialization of novel anti-infectives for the treatment of diseases. The Zacks Consensus Estimate for its current year earnings has been revised 16% downward over the last 60 days.
Oaktree Specialty Lending Corporation (OCSL - Free Report) is a business development company specializing in investments in middle market, bridge financing, first and second lien debt financing, mezzanine debt and more. The Zacks Consensus Estimate for its current year earnings has been revised 5.9% downward over the last 60 days.
View the entire Zacks Rank #5 List.